CN105664022A - 一种治疗子宫癌的中药组合物制剂及其制备方法 - Google Patents
一种治疗子宫癌的中药组合物制剂及其制备方法 Download PDFInfo
- Publication number
- CN105664022A CN105664022A CN201610075507.2A CN201610075507A CN105664022A CN 105664022 A CN105664022 A CN 105664022A CN 201610075507 A CN201610075507 A CN 201610075507A CN 105664022 A CN105664022 A CN 105664022A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- composition preparation
- blood
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 title abstract description 20
- 238000000034 method Methods 0.000 title description 2
- 239000008280 blood Substances 0.000 claims abstract description 50
- 210000004369 blood Anatomy 0.000 claims abstract description 49
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 28
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 24
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 24
- 239000002775 capsule Substances 0.000 claims abstract description 15
- 244000207620 Euterpe oleracea Species 0.000 claims abstract description 13
- 235000012601 Euterpe oleracea Nutrition 0.000 claims abstract description 13
- 235000003650 acai Nutrition 0.000 claims abstract description 13
- 241000220215 Moringa Species 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 26
- 208000012991 uterine carcinoma Diseases 0.000 claims description 24
- 241000190633 Cordyceps Species 0.000 claims description 22
- 239000009969 fructus bruceae Substances 0.000 claims description 18
- 241000903946 Clematidis Species 0.000 claims description 17
- 241000283956 Manis Species 0.000 claims description 17
- 239000008517 radix Trichosanthis Substances 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 12
- 241000158621 Brucea Species 0.000 claims description 11
- 229920000858 Cyclodextrin Polymers 0.000 claims description 10
- 229940064008 acai berry extract Drugs 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000001116 FEMA 4028 Substances 0.000 claims description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 235000015800 acai extract Nutrition 0.000 claims description 5
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 5
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 5
- 229960004853 betadex Drugs 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 15
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 201000011510 cancer Diseases 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000004087 circulation Effects 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 240000004638 Dendrobium nobile Species 0.000 abstract 1
- 241000270290 Gekkota Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241001558017 Gynura Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 244000179886 Moringa oleifera Species 0.000 abstract 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000097577 Rhus javanica Species 0.000 abstract 1
- 235000010889 Rhus javanica Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 240000003248 Zanthoxylum nitidum Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010008342 Cervix carcinoma Diseases 0.000 description 5
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 5
- 201000010881 cervical cancer Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000025421 tumor of uterus Diseases 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000001741 anti-phlogistic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000009286 sanguis draxonis Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- KDPFMRXIVDLQKX-ISGXEFFDSA-N (+)-Curdione Natural products CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)/CC1=O KDPFMRXIVDLQKX-ISGXEFFDSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- KDPFMRXIVDLQKX-NHFJXKHHSA-N Germacr-1(10)-ene-5,8-dione Chemical compound CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)\CC1=O KDPFMRXIVDLQKX-NHFJXKHHSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000000448 cultured tumor cell Anatomy 0.000 description 1
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 1
- KDPFMRXIVDLQKX-UHFFFAOYSA-N curdione Natural products CC(C)C1CC(=O)C(C)CCC=C(C)CC1=O KDPFMRXIVDLQKX-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- DFNZYFAJQPLJFI-UHFFFAOYSA-N gentianine Chemical compound O=C1OCCC2=C1C=NC=C2C=C DFNZYFAJQPLJFI-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- NCTHNHPAQAVBEB-WGCWOXMQSA-M sodium ferulate Chemical compound [Na+].COC1=CC(\C=C\C([O-])=O)=CC=C1O NCTHNHPAQAVBEB-WGCWOXMQSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗子宫癌的中药组合物制剂,原料主要由以下组分按重量份配比制成:蛤蚧3~10份、生甲片4~10份、穿山甲血1~5份、雅胆子1~3份、山豆根1~3份、辣木5~15份、巴西莓5~16份、白背三七5~15份、三七花10~30份、川芎8~25份、当归6~15份、莪术2~8份、血褐2~6份、龙胆1~5份、石斛5~15份、冬虫夏草2~6份、西洋参2~6份、威灵仙4~10份、天花粉7~15份、两面针1~5份、甘草8~40份;本发明优选制成胶囊剂。本发明通过中药的合理配伍,以扶正固本、活血化瘀、行气止痛、阻断癌细胞、提高机体免疫力,最终达到治愈子宫癌的目的。
Description
技术领域
本发明涉及中药技术领域,特别是一种治疗子宫癌的中药组合物制剂及其制备方法。
背景技术
子宫癌是妇科最常见的恶性肿瘤之一,子宫癌包括宫体癌(又称子宫内膜癌)和宫颈癌。在全球范围内,每年约有20多万女性死于宫颈癌,在发展中国家,宫颈癌则属于常见多发的妇科肿瘤,排行榜首。子宫癌是指发生在子宫阴道部及宫颈管的恶性肿瘤,宫颈癌的转移,可向邻近组织和器官直接蔓延,向下至阴道穹窿及阴道壁,向上可侵犯子宫体,向两侧可侵犯盆腔组织,向前可侵犯膀胱,向后可侵犯直肠。
目前旨在治疗子宫肿瘤的中药,主要存在几个方面的不足:一是药效不显著;二是见效比较迟缓;三是不能标本兼治。很多子宫癌患者因药物不能有效控制肿瘤的生长、转移和扩散,或不服用药物以后又复发,从而影响了生存的时间。
发明内容
本发明提供了一种治疗子宫癌的中药组合物制剂及其制备方法,制得的中药组合物制剂对子宫癌有显著的治疗效果。
为实现上述目的,本发明的技术方案为:
一种治疗子宫癌的中药组合物制剂,原料主要由以下组分按重量份配比制成:
蛤蚧3~10份、生甲片4~10份、穿山甲血1~5份、雅胆子1~3份、山豆根1~3份、辣木5~15份、巴西莓5~16份、白背三七5~15份、三七花10~30份、川芎8~25份、当归6~15份、莪术2~8份、血褐2~6份、龙胆1~5份、石斛5~15份、冬虫夏草2~6份、西洋参2~6份、威灵仙4~10份、天花粉7~15份、两面针1~5份、甘草8~40份。
以上所述治疗子宫癌的中药组合物制剂,优选主要由以下组分按重量份配比制成:蛤蚧6份、生甲片7份、穿山甲血3份、雅胆子2份、山豆根2份、辣木10份、巴西莓12份、白背三七10份、三七花20份、川芎17份、当归12份、莪术5份、血褐4份、龙胆3份、石斛10份、冬虫夏草4份、西洋参4份、威灵仙7份、天花粉11份、两面针4份、甘草17份。
以上所述治疗子宫癌的中药组合物制剂,可按药剂学方法加入常规辅料制成临床接受的任意剂型;作为优选,所述剂型为胶囊剂。
优选的,所述辣木选用的为辣木根茎。
以上所述的治疗子宫癌的中药组合物制剂的制备方法,包括以下步骤:
(1)按重量份称取下列组分:蛤蚧3~10份、生甲片4~10份、穿山甲血1~5份、雅胆子1~3份、山豆根1~3份、辣木5~15份、巴西莓5~16份、白背三七5~15份、三七花10~30份、川芎8~25份、当归6~15份、莪术2~8份、血褐2~6份、龙胆1~5份、石斛5~15份、冬虫夏草2~6份、西洋参2~6份、威灵仙4~10份、天花粉7~15份、两面针1~5份、甘草8~40份;
(2)生甲片和冬虫夏草分别研磨成粉末;
(3)鸦胆子提取制成鸦胆子油,备用;
(4)巴西莓提取制成巴西莓提取物,备用;
(5)蛤蚧、生甲片粉末、穿山甲血、山豆根、辣木、白背三七、三七花、川芎、当归、莪术、血褐、龙胆、石斛、西洋参、威灵仙、天花粉、两面针和甘草,加入上述组分6~10倍重量的水,加热提取2~3次,每次1~2小时,滤过,合并滤液,滤液浓缩成稠膏,加入冬虫夏草粉末、巴西莓提取物及适量淀粉,干燥、粉碎,得干膏粉;
(6)取鸦胆子油,用6~10倍重量的倍他环糊精包结成倍他环糊精包结物,加入干膏粉、硬脂酸镁和微晶纤维素,混匀,制成颗粒,装入胶囊,即得胶囊剂。
本发明的中药组合物制剂主要蛤蚧、生甲片、穿山甲血、雅胆子、山豆根、辣木、巴西莓、白背三七、三七花、川芎、当归、莪术、血褐、龙胆、石斛、冬虫夏草、西洋参、威灵仙、天花粉、两面针和甘草组成,方中各中药的功效为:
蛤蚧:据《日华子本草》记载,可治肺气,止嗽,并通月经,下石淋及治血;
生甲片:消肿溃痈,搜风活络,通经下乳;用于治疗痈疽疮种,风寒湿痹,月经停闭;
穿山甲血:用于治疗通经下乳,消肿排脓,关节痹痛,麻木拘挛等病症;
雅胆子:鸦胆子油具有较好的抗癌效果,主要使用在肺癌、宫颈癌还有消化道方面的肿瘤;鸦胆子油一方面可以抑制肿瘤细胞DNA进行复制产生越来越多的肿瘤细胞,另外一方面可以直接进入到癌症细胞的内部,然后让细胞坏死,排出到人体的体外,或者被人体的吞噬细胞吞噬;
山豆根:有清热解毒,消肿利咽之功效;据《本草经疏》记载,山豆根,甘所以和毒,寒所以除热,凡毒必热必辛,得清寒之气,甘苦之味,则诸毒自解,故为解毒清热之上药;
辣木:是含有丰富高营养价值的植物,具有高蛋白、低脂质、高纤维、高维生素的优点,含有维它命A、B、C和蛋白质、钙、钾、铁等矿物质;可增强体力、治疗贫血、抑制病菌、驱除寄生虫;
巴西莓:可帮助伤口愈合、清血,改善贫血、腹泻、发烧、出血、黄疸、肝脏疾病等病症;含有维生素A、B1、B2、B3、B6和B12、还有维生素C、D、E以及十七种主要矿物,其中的抗氧化物和维生素A、C及E,可有效加速人体细胞生长,修补受损肌肤;
白背三七:具有降血糖、清热凉血、活血止痛、止血之功效;
三七花:具有清热、平肝、降压之功效,近年来的研究表明,三七中含有三七皂苷、β-榄香烯、微量元素硒等抗癌活性物质;三七皂苷120ug/ml浓度的Rb1能使培养的肿瘤细胞92%受到抑制,三七皂苷Rd的抑制率则为79%;三七皂苷Rh1对培养的肝癌细胞有明显的抑制作用;三七皂苷Rh2具有较强的抗肿瘤活性,并能诱导癌细胞逆转成非癌细胞;此外,三七皂苷和三七多糖能增强机体免疫功能,对治疗癌症有一定的辅助作用;
川芎:用于活血行气,祛风止痛,川芎辛温香燥,走而不守,既能行散,上行可达巅顶;又入血分,下行可达血海;可补肝血,润肝燥,补风虚;
当归:具有补血和血,调经止痛,润燥滑肠、抗癌、抗老防老、免疫之功效;还可广泛用于各种肿瘤,尤其是妇科肿瘤,以气血停滞、瘀血凝聚者最宜;当归及其萃取物阿魏酸钠和当归多醣对单核-巨噬细胞系统有明显的刺激作用,对免疫功能低下的机体也有免疫调解和恢复作用;
莪术:主治气血凝滞、心腹胀痛、症瘕、积聚、宿食不消、妇女血瘀经闭、跌打损伤作痛;块根称“绿丝郁金”,有行气解郁、破瘀、止痛的功用;莪术含有的莪术醇和莪术双酮,能直接抑制破坏肿瘤细胞,而且还可增强细胞的免疫原性,从而促进机体对肿瘤的免疫反应;
血竭:具有活血定痛,化瘀止血,生肌敛疮的功效;
龙胆:用于湿热黄疽、阴肿阴痒、带下、湿疹瘙痒、耳聋、胁痛、口苦、惊风抽搐;龙胆含有的龙胆碱具有显著的抗炎效果;
石斛:益胃生津,滋阴清热。用于阴伤津亏,口干烦渴,食少干呕,病后虚热,目暗不明;据《本经》记载,石斛主伤中,除痹,下气,补五脏虚劳羸瘦,强阴,久服厚肠胃;
冬虫夏草:可以增强机体的免疫力,滋补肺肾;可使自然杀伤细胞的活性增强,从而在抗癌、抗病毒感染中起重要作用;
西洋参:补气养阴,清热生津;是补气保健首选药材,可以促进血清蛋白合成、骨髓蛋白合成、器官蛋白合成等,提高机体免疫力,抑制癌细胞生长,有效抵抗癌症;
威灵仙:祛风除湿,通络止痛;用于风湿痹痛,肢体麻木,筋脉拘挛,屈伸不利,骨哽咽喉;
天花粉:清热泻火,生津止渴,排脓消肿;主治:治热病口渴、消渴、黄疸、肺燥咳血、痈肿、痔痿;
两面针:活血化瘀,行气止痛,祛风通络,解毒消肿,两面针还具有较好的抗炎效果;
甘草:功能主治清热解毒、祛痰止咳、脘腹等;也可用于调和某些药物的烈性。
本发明中,蛤蚧、鸦胆子、三七花、莪术具有杀灭癌细胞的作用;生甲片、穿山甲血、白背三七、川芎、当归、血竭、威灵仙和两面针具有活血化瘀、祛风止痛的功效;三七花、冬虫夏草、西洋参具有增强免疫力的功效,对抗肿瘤也有一定的辅助作用;山豆根用于解毒清热;龙胆、甘草和两面针具有抗炎功效;甘草用于调和烈性药物的药性,减轻药物对胃等器官的刺激作用;辣木、巴西莓、西洋参、石斛和天花粉可益胃生津,补充人体所需的维生素及矿物质,改善患者在对抗癌症过程中出现的恶心、消瘦、乏力、胃口不好等不良症状,降低药物对人体的损伤;本发明通过上述中药的合理配伍,以扶正固本、活血化瘀、行气止痛、阻断癌细胞、提高机体免疫力,最终达到治愈子宫癌的目的。
具体实施方式
以下结合具体实施例对本发明作进一步说明,但本发明的保护范围不限于以下实施例:
一、治疗子宫癌的中药组合物制剂的制备
实施例1
一种治疗子宫癌的中药组合物制剂,原料主要由以下组分按重量份配比制成:蛤蚧6份、生甲片7份、穿山甲血3份、雅胆子2份、山豆根2份、辣木10份、巴西莓12份、白背三七10份、三七花20份、川芎17份、当归12份、莪术5份、血褐4份、龙胆3份、石斛10份、冬虫夏草4份、西洋参4份、威灵仙7份、天花粉11份、两面针4份、甘草17份。
所述辣木选用的为辣木根茎。
上述中药组合物制剂的制备方法为:
(1)按重量份称取上述配方中的组分;
(2)生甲片和冬虫夏草分别研磨成粉末;
(3)鸦胆子提取制成鸦胆子油,备用;
(4)巴西莓提取制成巴西莓提取物,备用;
(5)蛤蚧、生甲片粉末、穿山甲血、山豆根、辣木、白背三七、三七花、川芎、当归、莪术、血褐、龙胆、石斛、西洋参、威灵仙、天花粉、两面针和甘草,加入上述组分6~10倍重量的水,加热提取2~3次,每次1~2小时,滤过,合并滤液,滤液浓缩成稠膏,加入冬虫夏草粉末、巴西莓提取物及适量淀粉,干燥、粉碎,得干膏粉;
(6)取鸦胆子油,用6~10倍重量的倍他环糊精包结成倍他环糊精包结物,加入干膏粉、硬脂酸镁和微晶纤维素,混匀,制成颗粒,装入胶囊,即得胶囊剂。
实施例2
一种治疗子宫癌的中药组合物制剂,原料主要由以下组分按重量份配比制成:蛤蚧3份、生甲片4份、穿山甲血1份、雅胆子1份、山豆根1份、辣木5份、巴西莓5份、白背三七5份、三七花10份、川芎8份、当归6份、莪术2份、血褐2份、龙胆1份、石斛5份、冬虫夏草2份、西洋参2份、威灵仙4份、天花粉7份、两面针1份、甘草8份。
所述辣木选用的为辣木根茎。
上述中药组合物制剂的制备方法为:
(1)按重量份称取上述配方中的组分;
(2)生甲片和冬虫夏草分别研磨成粉末;
(3)鸦胆子提取制成鸦胆子油,备用;
(4)巴西莓提取制成巴西莓提取物,备用;
(5)蛤蚧、生甲片粉末、穿山甲血、山豆根、辣木、白背三七、三七花、川芎、当归、莪术、血褐、龙胆、石斛、西洋参、威灵仙、天花粉、两面针和甘草,加入上述组分6~10倍重量的水,加热提取2~3次,每次1~2小时,滤过,合并滤液,滤液浓缩成稠膏,加入冬虫夏草粉末、巴西莓提取物及适量淀粉,干燥、粉碎,得干膏粉;
(6)取鸦胆子油,用6~10倍重量的倍他环糊精包结成倍他环糊精包结物,加入干膏粉、硬脂酸镁和微晶纤维素,混匀,制成颗粒,装入胶囊,即得胶囊剂。
实施例3
一种治疗子宫癌的中药组合物制剂,原料主要由以下组分按重量份配比制成:蛤蚧10份、生甲片10份、穿山甲血5份、雅胆子3份、山豆根3份、辣木15份、巴西莓16份、白背三七15份、三七花30份、川芎25份、当归15份、莪术8份、血褐6份、龙胆5份、石斛15份、冬虫夏草6份、西洋参6份、威灵仙10份、天花粉15份、两面针5份、甘草40份。
所述辣木选用的为辣木根茎。
上述中药组合物制剂的制备方法为:
(1)按重量份称取上述配方中的组分;
(2)生甲片和冬虫夏草分别研磨成粉末;
(3)鸦胆子提取制成鸦胆子油,备用;
(4)巴西莓提取制成巴西莓提取物,备用;
(5)蛤蚧、生甲片粉末、穿山甲血、山豆根、辣木、白背三七、三七花、川芎、当归、莪术、血褐、龙胆、石斛、西洋参、威灵仙、天花粉、两面针和甘草,加入上述组分6~10倍重量的水,加热提取2~3次,每次1~2小时,滤过,合并滤液,滤液浓缩成稠膏,加入冬虫夏草粉末、巴西莓提取物及适量淀粉,干燥、粉碎,得干膏粉;
(6)取鸦胆子油,用6~10倍重量的倍他环糊精包结成倍他环糊精包结物,加入干膏粉、硬脂酸镁和微晶纤维素,混匀,制成颗粒,装入胶囊,即得胶囊剂。
二、临床应用
1、病例的选择:
选择中医子宫肿瘤患者,经75例临床观察。
(1)纳入标准:
a.年龄在38-65岁之间的女性,平均年龄52.8岁。
b.中医诊断子宫癌为标准:肢软无力,虚损严重,小腹下坠,憋胀疼痛,子宫CT可见肿瘤。
c.能配合治疗,按时复诊的患者。
(2)排除标准
a.年龄在38岁以下或65岁以上者。
b.患有其它严重疾病
c.妊娠或准备妊娠妇女,哺乳期妇女。
d.过敏体质或对多种药物过敏者。
e.未按规定用药或中断治疗,无法判定疗效或资料不全等影响疗效或安全性判断者。
2、临床试验:
(1)疗效判定:
a.显效:体质增强,四肢有力,小腹不适明显缓解,CT显示子宫肿瘤瘤体缩小,其它部位未发现新生肿瘤。
b.有效:乏力症状有所改善,小腹不适有所缓解,子宫肿瘤瘤体未见增长,其它部位未发现新生肿瘤。
c.无效:病症无变化,子宫肿瘤瘤体增大,或其它部位发现新生肿瘤。
(2)临床实验时,停服其它药物和保健营养品。服用本发明中实施例1~3的制剂(每个实施例经25例患者临床观察),观察3个月,为一个疗程。服用方法:每日3次,每次6粒胶囊,每粒胶囊内含中药细粉及提取物0.25克,饭后温开水送服,结果详见下表:
组别 | 显效 | 有效 | 无效 | 有效率 |
实施例1 | 13 | 10 | 2 | 92% |
实施例2 | 10 | 12 | 3 | 88% |
实施例3 | 10 | 10 | 5 | 80% |
结果表明:采用本发明实施例1~3进行治疗,其中,实施例1的效果最佳,有效率达到92%,实施例2、3的有效率也在80%以上,本发明总体效果较好,能明显改善患者乏力、疼痛、厌食、消瘦小腹不适等症状,精神状态良好。
Claims (6)
1.一种治疗子宫癌的中药组合物制剂,其特征在于,原料主要由以下组分按重量份配比制成:
蛤蚧3~10份、生甲片4~10份、穿山甲血1~5份、雅胆子1~3份、山豆根1~3份、辣木5~15份、巴西莓5~16份、白背三七5~15份、三七花10~30份、川芎8~25份、当归6~15份、莪术2~8份、血褐2~6份、龙胆1~5份、石斛5~15份、冬虫夏草2~6份、西洋参2~6份、威灵仙4~10份、天花粉7~15份、两面针1~5份、甘草8~40份。
2.根据权利要求1所述的治疗子宫癌的中药组合物制剂,其特征在于,原料主要由以下组分按重量份配比制成:
蛤蚧6份、生甲片7份、穿山甲血3份、雅胆子2份、山豆根2份、辣木10份、巴西莓12份、白背三七10份、三七花20份、川芎17份、当归12份、莪术5份、血褐4份、龙胆3份、石斛10份、冬虫夏草4份、西洋参4份、威灵仙7份、天花粉11份、两面针4份、甘草17份。
3.根据权利要求1~2任一项所述的治疗子宫癌的中药组合物制剂,其特征在于:
所述中药组合物制剂按药剂学方法加入常规辅料制成临床接受的任意剂型。
4.根据权利要求3所述的治疗子宫癌的中药组合物制剂,其特征在于:
所述剂型为胶囊剂。
5.根据权利要求1所述的治疗子宫癌的中药组合物制剂,其特征在于:
所述辣木选用的为辣木根茎。
6.根据权利要求1所述的一种治疗子宫癌的中药组合物制剂的制备方法,其特征在于包括以下步骤:
(1)按重量份称取下列组分:蛤蚧3~10份、生甲片4~10份、穿山甲血1~5份、雅胆子1~3份、山豆根1~3份、辣木5~15份、巴西莓5~16份、白背三七5~15份、三七花10~30份、川芎8~25份、当归6~15份、莪术2~8份、血褐2~6份、龙胆1~5份、石斛5~15份、冬虫夏草2~6份、西洋参2~6份、威灵仙4~10份、天花粉7~15份、两面针1~5份、甘草8~40份;
(2)生甲片和冬虫夏草分别研磨成粉末;
(3)鸦胆子提取制成鸦胆子油,备用;
(4)巴西莓提取制成巴西莓提取物,备用;
(5)蛤蚧、生甲片粉末、穿山甲血、山豆根、辣木、白背三七、三七花、川芎、当归、莪术、血褐、龙胆、石斛、西洋参、威灵仙、天花粉、两面针和甘草,加入上述组分6~10倍重量的水,加热提取2~3次,每次1~2小时,滤过,合并滤液,滤液浓缩成稠膏,加入冬虫夏草粉末、巴西莓提取物及适量淀粉,干燥、粉碎,得干膏粉;
(6)取鸦胆子油,用6~10倍重量的倍他环糊精包结成倍他环糊精包结物,加入干膏粉、硬脂酸镁和微晶纤维素,混匀,制成颗粒,装入胶囊,即得胶囊剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610075507.2A CN105664022A (zh) | 2016-02-03 | 2016-02-03 | 一种治疗子宫癌的中药组合物制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610075507.2A CN105664022A (zh) | 2016-02-03 | 2016-02-03 | 一种治疗子宫癌的中药组合物制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105664022A true CN105664022A (zh) | 2016-06-15 |
Family
ID=56303260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610075507.2A Withdrawn CN105664022A (zh) | 2016-02-03 | 2016-02-03 | 一种治疗子宫癌的中药组合物制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105664022A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109430564A (zh) * | 2018-12-29 | 2019-03-08 | 广西壮族自治区林业科学研究院 | 一种马来穿山甲专用饲料及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103611094A (zh) * | 2013-12-12 | 2014-03-05 | 王学玲 | 一种治疗宫颈癌的药物 |
CN103877508A (zh) * | 2014-03-28 | 2014-06-25 | 王俊杰 | 一种治疗子宫癌的中药组合物 |
-
2016
- 2016-02-03 CN CN201610075507.2A patent/CN105664022A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103611094A (zh) * | 2013-12-12 | 2014-03-05 | 王学玲 | 一种治疗宫颈癌的药物 |
CN103877508A (zh) * | 2014-03-28 | 2014-06-25 | 王俊杰 | 一种治疗子宫癌的中药组合物 |
Non-Patent Citations (3)
Title |
---|
周绪堂: "《实用肿瘤诊疗手册》", 30 November 1997, 江西科学技术出版社 * |
李冈荣: "《汉方中草药对症图典 第4册》", 30 September 2015, 新疆科技卫生出版社 * |
谢东浩: "《常用治疗肿瘤中药》", 31 October 2015, 中国医药科技出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109430564A (zh) * | 2018-12-29 | 2019-03-08 | 广西壮族自治区林业科学研究院 | 一种马来穿山甲专用饲料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100551422C (zh) | 一种治疗椎间盘突出的内服药物 | |
CN103893722B (zh) | 一种治疗日光性皮炎的中药组合物及其制备方法 | |
CN101711848B (zh) | 一种辅助治疗肿瘤的中药组合物 | |
CN103920034A (zh) | 减轻肿瘤病人化疗副反应的中药组合物及制法 | |
CN104906465A (zh) | 一种治疗妇女慢性盆腔炎的中药化瘀组合物及其制备方法 | |
CN104524071A (zh) | 一种治疗原发性肾病的药物组合物及其用途 | |
CN101417087B (zh) | 一种治疗妇科产后疾病的药物及其制备方法 | |
CN105664022A (zh) | 一种治疗子宫癌的中药组合物制剂及其制备方法 | |
CN106266109A (zh) | 一种治疗泌尿系统结石的中药组合物及其制备方法 | |
CN105770691A (zh) | 一种用于治疗宫颈癌的药物制剂及其用途 | |
CN104758701A (zh) | 一种胃结石碎石后护理治疗的药物及其制备方法 | |
CN105412621A (zh) | 一种制备治疗痔疮的药物组合物的方法 | |
CN105343578A (zh) | 一种治疗痔疮的药物组合物 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN105617264A (zh) | 一种治疗子宫癌的中药组合物制剂及其生产工艺 | |
CN103301373A (zh) | 一种治疗产后会阴粘膜病变的药物组合物 | |
CN105664023A (zh) | 一种治疗子宫癌的中药组合物及其生产工艺 | |
CN102688453A (zh) | 一种治疗乳腺癌的中药组合物 | |
CN105561202A (zh) | 一种治疗子宫癌的中药组合物 | |
CN105617265A (zh) | 一种治疗子宫癌的中药组合物及其制备方法 | |
CN105561201A (zh) | 一种治疗子宫癌的中药组合物制剂 | |
CN107334941A (zh) | 一种治疗慢性盆腔炎的中药及其制备方法 | |
CN101869629B (zh) | 一种治疗肾结石的中药 | |
CN105963619A (zh) | 一种治疗宫寒不孕的中药组合物 | |
CN105031335A (zh) | 一种胃结石微波碎石后护理治疗的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170527 Address after: 530022 Building 2, building 15, building 6, bureau of seismology, No. 33, Gucheng Road, the Guangxi Zhuang Autonomous Region, Nanning, 6415 Applicant after: Li Xiaoting Address before: 530007 the Guangxi Zhuang Autonomous Region high tech Avenue, No. 62 Guanghui building, No. 1419, Nanning Applicant before: Nanning Pindi Biological Engineering Co., Ltd. |
|
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160615 |